|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/495 | (2006.01) |
| A61P 9/06 | (2006.01) |
| (11) | Number of the document | 1930007 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08004276.5 |
| Date of filing the European patent application | 2003-04-04 | |
| (97) | Date of publication of the European application | 2008-06-11 |
| (45) | Date of publication and mention of the grant of the patent | 2010-06-09 |
| (46) | Date of publication of the claims translation | 2010-09-27 |
| (30) | Number | Date | Country code |
| 370150 P | 2002-04-04 | US | |
| 408292 P | 2002-09-05 | US | |
| 422589 P | 2002-10-30 | US |
| (72) |
Belardinelli, Luiz, US
Antzelevitch, Charles, US
Blackburn, Brent, US
|
| (73) |
Gilead Sciences, Inc.,
333 Lakeside Drive, Foster City, CA 94404,
US
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Ranolazino panaudojimas medikamento, skirto ankstyvosios post-depoliarizacijos (EADs) gydymui, gamyboje |
| Use of ranolazine for the preparation of a medicament for the treatment of early afterdepolarisations (EADs) |
| Payment date | Validity (years) | Amount | |
| 2019-03-19 | 17 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2020-04-04 |